Aktie A2JMYV BOULE DIAGNOSTICS AB
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Boule Diagnostics AB

Aktien

A2JMYV

SE0011231158

BOUL

Verzögert Nasdaq Stockholm
Andere Börsenplätze
 15:37:16 25.04.2024 		% 5 Tage % 1. Jan.
9,4 SEK -1,67 % Intraday Chart für Boule Diagnostics AB -4,86 % -16,22 %
06.02. Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024
06.02. Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Boule Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Boule Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023
Boule Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Boule Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Boule Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023
Boule Diagnostics : interim report Q4 2022
Boule Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
Boule Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Boule Diagnostics AB announced that it has received funding from Keel Capital Ab
Boule Diagnostics : Partnership for free diagnostic services
Boule Diagnostics : The utility of CBC results in initial fever investigations
Boule Diagnostics : Q2 2022 presentation.
Boule Diagnostics : Q2 2022 presentation
Boule Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Boule Diagnostics : appoints David Metrena to lead US commercial organization
Boule Diagnostics : Reducing turnaround time (TAT) of test results with Swelab
Boule Diagnostics : Reducing turnaround time (TAT) of test results with Swelab Alfa Plus
Boule Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2022
Boule Diagnostics : Annual report 2021
Boule Diagnostics : profile interview – Dr. Charles Adeogun
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2JMYV Aktie
  4. Nachrichten Boule Diagnostics AB
  5. Andere Sprachen